Electromechanical Mapping to Evaluate Heart Muscle

PHASE3CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

August 31, 1999

Study Completion Date

December 31, 2001

Conditions
Myocardial Ischemia
Interventions
DRUG

FDG

DRUG

NH(3)

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001895 - Electromechanical Mapping to Evaluate Heart Muscle | Biotech Hunter | Biotech Hunter